Intravenous immunoglobulin modulates the maturation of TLR 4-primed peripheral blood monocytes

Clinical Immunology

Volumn 139, Issue 2, 2011, Pages 208-214

  Ballow, Mark ^a,b   Allen, Cheryl ^a  

^a CHILDREN S HOSPITAL OF BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Dendritic cell maturation; Dendritic cells; Immune modulation; Intravenous immunoglobulin; TLR agonists; Toll like receptors

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN F(AB')2 FRAGMENT; INTERLEUKIN 4; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; ENDOCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOID TISSUE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ANTIGEN PRESENTATION; ANTIGENS, CD; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; ENDOCYTOSIS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULINS, INTRAVENOUS; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; MONOCYTES; MYELOID DIFFERENTIATION FACTOR 88; RECEPTORS, CCR5; RECEPTORS, CCR7; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 79954591046     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.02.006     Document Type: Article

References (30)

1. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18:767-811.
2. Guermonprez P., Valladeau J., Zitvogel L., Thery C., Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 2002, 20:621-667.
3. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2001, 2:675-680.
4. Lee H.K., Iwasaki A. Innate control of adaptive immunity: dendritic cells and beyond. Semin. Immunol. 2007, 19:48-55.
5. de Jong E.C., Smits H.H., Kapsenberg M.L. Dendritic cell-mediated T cell polarization. Springer Semin. Immun. 2005, 26:289-307.
6. Kapsenberg M.L. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 2003, 3:984-993.
7. Ballow M. Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases. J. Allergy Clin. Immunol. 1997, 100:151-157.
8. Ballow M. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders. J. Allergy Clin. Immunol. 2011, 127:315-323.
9. Dalakas M.C. Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases. Neurology 1998, 51:2-8.
10. Kazatchkine M.D., Kaveri S.V. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N. Engl. J. Med. 2001, 345:747-755.
11. Nimmerjahn F., Ravetch J.V. Anti-inflammatory actions of intravenous immunoglobulin. Annu. Rev. Immunol. 2008, 26:513-533.
12. Bayry J., Lacroix-Desmazes S., Carbonneil C., Misra N., Donkova V., Pashov A., Chevailler A., Mouthon L., Weill B., Bruneval P., Kazatchkine M.D., Kaveri S.V. Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood 2003, 101:758-765.
13. Bykovskaia S., Shurin G., Graner S., Bunker M., Olson W., Thomas R., Shurin M., Marks S., Storkus W., Shogan J. Differentiation of immunostimulatory stem-cell- and monocyte-derived dendritic cells involves maturation of intracellular compartments responsible for antigen presentation and secretion. Stem Cells 2002, 20:380-393.
14. Cella M., Sallusto F., Lanzavecchia A. Origin, maturation, and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 1997, 9:10-16.
15. Palucka K., Taquet N., Sanchez-Chapuis F., Gluckman J. Dendritic cells as the terminal stage of monocyte differentiation. J. Immunol. 1998, 160:4587-4595.
16. Zhou L.-J., Tedder T. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl Acad. Sci. USA 1996, 93:2588-2592.
17. Eisenbarth S., Piggott D., Huleatt J., Visintin I., Herrick C., Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type responsives to inhaled antigen. J. Exp. Med. 2002, 196:1645-1651.
18. Fritz J., Girardin S., Fitting C., Werts C., Mengin-Lecreulx D., Caroff M., Cavaillon J., Philpott D., Adib-Conquy M. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists. Eur. J. Immunol. 2005, 35:2459-2470.
19. Lore K., Betts M., Brenchley J., Kuruppu J., Khojasteh S., Perfeto S., Roederer M., Seder R., Koup R. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus and HIV-1 specific T cell responses. J. Immunol. 2003, 171:4320-4328.
20. Mattern T., Flad H., Brade L., Rietschel E., Ulmer A. Stimulation of human T lymphocytes by LPS is MHC unrestricted, but strongly dependent on B7 interactions. J. Immunol. 1998, 160:3412-3418.
21. Okhuma K., Sasaki T., Kamei S., Okuda S., Nakano H., Hamamoto T., Fujihara K., Nakashima I., Misu T., Itoyama Y. Modulation of dendritic cell development by immunoglobulin G in control subjects and multiple sclerosis patients. Clin. Exp. Immunol. 2007, 150:397-406.
22. St.Amour I., Laroche A., Bazin R., Lemieux R. Activation of cryptic IgG reactive with BAFF, amyloid beta peptide and GM-CSF during the industrial fractionation of human plasma into therapeutic intravenous immunoglobulins. Clin. Immunol. 2009, 133:52-60.
23. Sallusto F., Schaerli P., Loetscher P., Schaniel C., Lenig D., Mackay C. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 1998, 28:2760-2769.
24. Van den Elsen P., Rudensky A. Antigen processing and recognition. Recent developments. Curr. Opin. Immunol. 2004, 16:63-66.
25. Siragam V., Crow A., Brinc D., Song S., Freedman J., Lazarus A. Intravenous immuoglobulin ameliorates ITP via activating Fcg receptors on dendritic cells. Nat. Med. 2006, 12:688-692.
26. Boruchov A.M., Heller G., Veri M.C., Bonvini E., Ravetch J.V., Young J.W. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J. Clin. Invest. 2005, 115:2914-2923.
27. Prechtel A. CD83: an pdate on functions and prospects of the maturation marker of dendritic cells. Arch. Dermatol. Res. 2007, 299:59-69.
28. Prechtel A., Turza N., Theodoridis A., Steinkasserer A. CD83 knockdown in moonocyte-derived dendritic cells by small interfering RNA leads to a diminished T cell stimulation. J. Immunol. 2007, 178:5454-5464.
29. Hirano N., Butler M., Xia Z., Ansen S., von Bergwelt-Baidon M., Neuberg D., Freeman G. Engagement of CD83 ligand induced prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity. Blood 2006, 107:1528-1536.
30. Reinwald S., Wiethe C., Westendoef A., Breloer M., Probst-Kepper M., Fleisher B., Steinkasserer A., Buer J., Hansen W. CD83 expression in CD4+ T cells modulates inflammation and autoimmunity. J. Immunol. 2008, 180:5890-5897.